Aneta Borkowska

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat et al. · The Lancet Oncology · 2019 · 469 citations · Full text

Radiation Medicine, Radiation Therapy, Medicine +10

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone – Multicenter analysis outside clinical trial

Piotr Rutkowski, Louie Gaston, Aneta Borkowska et al. · European Journal of Surgical Oncology · 2018 · 110 citations · Full text

Denosumab Treatment, Surgical Oncology, Malignant Disease +6

Denosumab treatment of inoperable or locally advanced giant cell tumor of bone

Aneta Borkowska, Tomasz Goryń, Andrzej Pieńkowski et al. · Oncology Letters · 2016 · 40 citations · Full text

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial

Hanna Koseła-Paterczyk, Mateusz Spałek, Aneta Borkowska et al. · Journal of Clinical Medicine · 2020 · 35 citations · Full text

Combined Preoperative Hypofractionated Radiotherapy With Doxorubicin-Ifosfamide Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Results of a Phase 2 Clinical Trial

Mateusz Spałek, Hanna Koseła-Paterczyk, Aneta Borkowska et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 32 citations

Surgical Oncology, Radiation Therapy, Medicine +7